An internal standard for the quantification of indoramin
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Indoramin-d5

Item No. 45855

Technical Information
Formal Name
N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidinyl]-benzamide-2,3,4,5,6-d5
CAS Number
57165-41-0
Molecular Formula
C22H20D5N3O
Formula Weight
Purity
≥99% deuterated forms (d1-d5)
A 1 mg/ml solution in methanol
SMILES
O=C(C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H])NC(CC2)CCN2CCC3=CNC4=CC=CC=C34
InChi Code
InChI=1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26)/i1D,2D,3D,6D,7D
InChi Key
JXZZEXZZKAWDSP-FSTBWYLISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Indoramin-d5 is intended for use as an internal standard for the quantification of indoramin by GC- or LC-MS. Indoramin is an antagonist of α1-adrenergic receptors (α1-ARs; Kis = 5, 10, and 50 nM for the human α1A-, α1B-, and α1D-ARs, respectively).1 It also binds to α1L-ARs (pA2 = 8.5) and inhibits norepinephrine and serotonin (5-HT) uptake in rat brain cortical slices (IC50 = 2 µM for both).2,3 Indoramin (5 mg/kg) decreases blood pressure in normotensive anesthetized rats.4 Intrathecal administration of indoramin decreases micturition pressure and increases bladder capacity and micturition volume in conscious rats.5 Formulations containing indoramin have been used in the treatment of urinary outflow obstruction in patients with benign prostatic hyperplasia.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kenny, B.A., Miller, A.M., Williamson, I.J.R., et alEvaluation of the pharmacological selectivity profile of α1 adrenoceptor antagonists at prostatic α1 adrenoceptors: Binding, functional and in vivo studies. Br. J. Pharmacol. 118(4), 871-878 (1996).

    2. Ford, A.P.D.W., Arrendondo, N.F., Blue, D.R., Jr., et alRS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α, α-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective α1A-adrenoceptor antagonist, displays low affinity for functional α1-adrenoceptors in human prostate: Implications for adrenoceptor classification. Mol. Pharmacol. 49(2), 209-215 (1996).

    3. Sugden, R.F. The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices. Br. J. Pharmacol. 51(3), 467-469 (1974).

    4. Archibald, J.L., Alps, B.J., Cavalla, J.F., et alSynthesis and hypotensive activity of benzamidopiperidylethylindoles. J. Med. Chem. 14(11), 1054-1059 (1971).

    5. Ishizuka, O., Pandita, R.K., Mattiasson, A., et alStimulation of bladder activity by volume, L-dopa and capsaicin in normal conscious rats - effects of spinal α1-adrenoceptor blockade. Naunyn Schmiedebergs Arch. Pharmacol. 355(6), 787-793 (1997).